Shares of athenahealth, Inc (NASDAQ:ATHN) have earned a consensus rating of “Buy” from the twenty research firms that are currently covering the firm. One research analyst has rated the stock with a sell recommendation, eight have issued a hold recommendation and eleven have assigned a buy recommendation to the company. The average 12-month price target among analysts that have covered the stock in the last year is $132.82.
ATHN has been the topic of a number of research reports. Oppenheimer Holdings Inc. set a $142.00 price target on athenahealth and gave the company a “buy” rating in a research report on Saturday, February 4th. Robert W. Baird set a $155.00 price objective on athenahealth and gave the stock a “buy” rating in a report on Friday, February 3rd. Dougherty & Co reiterated a “buy” rating and issued a $150.00 price objective on shares of athenahealth in a report on Wednesday, December 28th. Berenberg Bank began coverage on athenahealth in a report on Tuesday, February 7th. They issued a “buy” rating and a $143.00 price objective on the stock. Finally, KeyCorp set a $140.00 price objective on athenahealth and gave the stock a “buy” rating in a report on Monday, February 6th.
ILLEGAL ACTIVITY WARNING: “Analysts Set athenahealth, Inc (ATHN) Price Target at $132.17” was published by Sports Perspectives and is owned by of Sports Perspectives. If you are viewing this piece on another website, it was copied illegally and republished in violation of United States and international trademark & copyright law. The original version of this piece can be accessed at https://sportsperspectives.com/2017/04/21/analysts-set-athenahealth-inc-athn-price-target-at-132-17-updated-updated.html.
In other news, Director John A. Kane sold 2,875 shares of the business’s stock in a transaction that occurred on Friday, January 27th. The stock was sold at an average price of $123.11, for a total value of $353,941.25. Following the sale, the director now directly owns 8,958 shares of the company’s stock, valued at approximately $1,102,819.38. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Insiders own 3.04% of the company’s stock.
A number of large investors have recently made changes to their positions in the stock. Fox Run Management L.L.C. raised its stake in shares of athenahealth by 27.3% in the first quarter. Fox Run Management L.L.C. now owns 6,621 shares of the health services provider’s stock worth $746,000 after buying an additional 1,421 shares in the last quarter. Bank of Montreal Can raised its stake in shares of athenahealth by 169.2% in the first quarter. Bank of Montreal Can now owns 44,156 shares of the health services provider’s stock worth $4,976,000 after buying an additional 27,753 shares in the last quarter. Peregrine Capital Management LLC bought a new stake in shares of athenahealth during the first quarter worth $19,343,000. Highbridge Capital Management LLC bought a new stake in shares of athenahealth during the fourth quarter worth $13,599,000. Finally, Teachers Advisors LLC raised its stake in shares of athenahealth by 3.0% in the fourth quarter. Teachers Advisors LLC now owns 74,094 shares of the health services provider’s stock worth $7,792,000 after buying an additional 2,190 shares in the last quarter.
Shares of athenahealth (NASDAQ:ATHN) traded down 0.75% on Monday, hitting $117.22. The stock had a trading volume of 500,752 shares. The company has a market cap of $4.63 billion, a PE ratio of 225.42 and a beta of 1.77. The stock’s 50-day moving average price is $113.42 and its 200 day moving average price is $112.12. athenahealth has a 52 week low of $90.11 and a 52 week high of $143.85.
athenahealth (NASDAQ:ATHN) last released its quarterly earnings results on Thursday, February 2nd. The health services provider reported $0.62 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.51 by $0.11. athenahealth had a return on equity of 6.41% and a net margin of 1.94%. The business had revenue of $288.20 million for the quarter, compared to the consensus estimate of $303.72 million. During the same quarter last year, the business posted $0.45 earnings per share. The company’s revenue for the quarter was up 11.9% on a year-over-year basis. On average, analysts predict that athenahealth will post $2.46 EPS for the current year.
athenahealth Company Profile
athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.
Receive News & Ratings for athenahealth Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc and related companies with MarketBeat.com's FREE daily email newsletter.